相关实验视频

Updated: May 28, 2025

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

用于帕金森病治疗的计算植物化学查:c-Abl及以上

Jesmina Yasmine¹, Piyong Sola¹, Emdormi Rymbai²

¹Department of Pharmacology, NETES Institute of Pharmaceutical Science, NEMCARE Group of Institutions, Mirza, Assam 781125, India.

Computational biology and chemistry

|February 14, 2025

概括

研究人员确定了可能抑制c-Abl的天然化合物,这是帕金森病 (PD) 发病的一个关键因素. 这些潜在的抑制剂通过向α-synuclein聚合来开发新的PD疗法.

科学领域:

神经科学是一个神经科学.
药理学药理学是指药理学的学科.
计算化学计算化学

背景情况:

帕金森病 (PD) 是一个日益增长的神经退行性疾病,与α-synuclein聚合物有关.
氨酸激酶c-Abl与帕金森病的发病有关.

研究的目的:

从天然产品中识别出新的c-Abl抑制剂.
评估这些天然化合物的潜力,以治疗帕金森病的治疗方法.

主要方法:

利用分子对接和动力学模拟.
从IMPPAT数据库中选的植物化学物质.
进行了毒性预测和密度功能理论 (DFT) 分析.

主要成果:

鉴定出了三种潜在的c-Abl抑制剂:IMPHY008934,IMPHY009589和IMPHY006310.
这些化合物与尼洛尼布具有相似的结合亲和力;IMPHY008934和IMPHY009589的预测毒性较低.
分子动力学证实了IMPHY009589和IMPHY008934与c-Abl的稳定性;DFT表明IMPHY006310和IMPHY008934的反应性增强.

结论:

已识别的天然化合物可能在帕金森病中准c-Abl.
这些化合物可能会降低过度表达的α-synuclein.
天然产品代表了新的帕金森病治疗方法的前景.

关键词:

在C-AblAbl中使用.密度函数理论分析密度函数理论分析疾病修饰药物疾病修饰药物分子对接是分子对接.分子动力学分子动力学神经保护是一种神经保护.帕金森病的疾病.植物化学品植物化学品

更多相关视频

High Content Screening in Neurodegenerative Diseases

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...